Skip to content

Silymarin

ALIMENTARY TRACT AND METABOLISM

ATC A05BA03

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Silymarin is a drug catalogued in DrugCentral. DrugCentral lists 19 molecular targets, including Ca15, PPO2 and CA1.

  • Molecular targets: Ca15, PPO2, CA1 and CA2 (19 listed in DrugCentral).
  • ATC code: A05BA03 (Liver therapy).

Mechanism & targets

Molecular targets (19)

TargetGeneActionActivity
Carbonic anhydrase 15Ca15unknownKi 6.19
Polyphenol oxidase 2PPO2unknownKi 6.16
Carbonic anhydrase 1CA1unknownKi 5.83
Carbonic anhydrase 2CA2unknownKi 5.60
Carbonic anhydrase 5A, mitochondrialCA5AunknownKi 5.39
Carbonic anhydrase 5B, mitochondrialCA5BunknownKi 5.34
Carbonic anhydrase 7CA7unknownKi 5.33
Carbonic anhydrase 13CA13unknownKi 5.32
Carbonic anhydrase 3CA3unknownKi 5.19
P-glycoprotein 3Abcb1aunknownKd 5.17
Carbonic anhydrase 4CA4unknownKi 5.05
Carbonic anhydrase 12CA12unknownKi 5.04
Carbonic anhydrase 6CA6unknownKi 5.01
Carbonic anhydrase 9CA9unknownKi 4.99
Carbonic anhydrase 14CA14unknownKi 4.93
ProthrombinF2unknownKd 4.73
Urokinase-type plasminogen activatorPLAUunknownIC50 4.68
Solute carrier family 2, facilitated glucose transporter member 4Slc2a4unknownKi 4.22
Xanthine dehydrogenase/oxidaseXdhunknownIC50 4.10

ATC classification

ATC codeTherapeutic hierarchy
A05BA03ALIMENTARY TRACT AND METABOLISM › BILE AND LIVER THERAPY › LIVER THERAPY, LIPOTROPICS › Liver therapy

Chemical structure

Molecular formula—
Molecular weight—
CAS number65666-07-1
InChIKey—
PubChem CID5213

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Silymarin work?

Its molecular targets in DrugCentral include Ca15, PPO2, CA1 and CA2.

Browse: all drugs starting with S · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets19
Indications0
Formula—
DrugCentral ID2443
Interactive profile